Structure September 2011 PMID 21885291

Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.

Andrew S Doré, Nathan Robertson, James C Errey, Irene Ng, Kaspar Hollenstein, Ben Tehan, Edward Hurrell, Kirstie Bennett, Miles Congreve, Francesca Magnani, Christopher G Tate, Malcolm Weir, Fiona H Marshall

Download social card

Mentions

8
Peak: 1 in Mar 2021
across 4 sources since Mar 2021

Extended reach

2,510
potential audience

Total likes

39

Video views

2,225

Mentions per month

Mar 2021 – Feb 2022

Where it's discussed

  • News3 articles
  • YouTube2 videos
  • Blogs2 articles
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions reflect a casual attitude towards the publication, with mentions of caffeine and biochemistry that suggest a basic interest but little engagement, such as 'Caffeine biochemistry' and comments about personal schedules and energy levels. The tone is relaxed and informal, emphasizing personal reactions rather than scientific implications.

AgreementNeither agree nor disagree

The posts do not explicitly agree or disagree with the scientific study but show a neutral or indifferent stance.

InterestModerate interest

There is a mild interest, especially in the mention of biochemistry and caffeine, which are relatable topics.

EngagementLow engagement

The comments are light and casual, indicating minimal deep involvement with the research details.

ImpactNeutral impact

The overall discussion does not seem to influence opinions or actions significantly; it remains casual and personal.

Abstract in brief

  • The study presents the crystal structures of the adenosine A2A receptor in complex with various ligands, including xanthines like caffeine, XAC, and the inverse agonist ZM241385, revealing its inactive state with a specific salt bridge called the ionic lock.
  • These structures offer new understanding of how different ligands bind within the receptor's pocket and highlight the receptor’s intracellular regions involved in signal transduction, which is important for developing drugs to treat conditions like Parkinson's disease.
  • Methylxanthines such as caffeine are common stimulants that work by blocking adenosine receptors, and the detailed structural data can help improve their therapeutic properties or develop new treatments for neurological diseases.]

Top posts

Most liked on X and Bluesky
Hannah Landis
@whohannah · X

It looks like she's doing this while she's on an eliptical. This is my kind of energy. Best part of today was finding this YouTube channel. Also send help, I will probably have to reschedule my Biochemistry test again Caffeine biochemistry https://t.co/HrCGABjyQo via @YouTube

Feb 14, 2022 · 286 followers View post →

All mentions

Hannah Landis
@whohannah · X

It looks like she's doing this while she's on an eliptical. This is my kind of energy. Best part of today was finding this YouTube channel. Also send help, I will probably have to reschedule my Biochemistry test again Caffeine biochemistry https://t.co/HrCGABjyQo via @YouTube

Feb 14, 2022 · 286 followers View post →